England et al., 2000 - Google Patents
A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor α chainsEngland et al., 2000
View HTML- Document ID
- 11716293458256094342
- Author
- England B
- Balasubramanian P
- Uings I
- Bethell S
- Chen M
- Schatz P
- Yin Q
- Chen Y
- Whitehorn E
- Tsavaler A
- Martens C
- Barrett R
- McKinnon M
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
Two series of peptides that specifically bind to the extracellular domain of the α chain of the human interleukin-5 receptor (IL-5Rα), but share no primary sequence homology to IL-5, were identified from libraries of random recombinant peptides. Affinity maturation …
- 108010002616 Interleukin-5 0 title abstract description 68
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
England et al. | A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor α chains | |
Schreiber et al. | The molecular basis for functional plasticity in type I interferon signaling | |
Kim et al. | Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18 | |
Gauzzi et al. | The amino-terminal region of Tyk2 sustains the level of interferon α receptor 1, a component of the interferon α/β receptor | |
Wang et al. | A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor α chain | |
Amara et al. | A versatile synthetic dimerizer for the regulation of protein–protein interactions | |
Leppänen et al. | Structural determinants of growth factor binding and specificity by VEGF receptor 2 | |
Tsetlin | Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: pharmacological tools and endogenous modulators | |
Li et al. | Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family | |
Saegusa et al. | The direct binding of insulin-like growth factor-1 (IGF-1) to integrin αvβ3 is involved in IGF-1 signaling | |
De Souza et al. | SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities | |
Yang et al. | Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2 | |
Goffin et al. | Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay | |
Lintz et al. | Crystal structure of QscR, a Pseudomonas aeruginosa quorum sensing signal receptor | |
Nicholson et al. | Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 | |
Rosenkilde et al. | Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74 | |
Groppe et al. | Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein | |
Da Silva et al. | Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production | |
Olofsson et al. | Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells | |
Harrison et al. | Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency | |
Harrison et al. | An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors | |
Keegan et al. | Interleukin 4 receptor: signaling mechanisms | |
Getschman et al. | Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23–dependent murine model | |
Goebel et al. | Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity | |
Cutrone et al. | Identification of critical residues in bovine IFNAR-1 responsible for interferon binding |